'Your heart forecast': A new approach for describing and communicating cardiovascular risk?

Heart

Volumn 96, Issue 9, 2010, Pages 708-713

  Wells, Susan ^a   Kerr, Andrew ^a,b   Eadie, Stewart ^c   Wiltshire, Chris ^d   Jackson, Rod ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c National Heart Foundation of New Zealand   (New Zealand)

^d Enigma Publishing Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SMOKING; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; CARDIOVASCULAR DISEASES; COMMUNICATION; FORECASTING; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 77951663192     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.191320     Document Type: Review

References (23)

1. Jackson R, Barham P, Bills J, et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993;307:107-110 (Pubitemid 23189574)
2. Mann JI, Crooke M, Fear H, et al. Guidelines for the detection and management of dyslipidaemia. N Z Med J 1993;106:133-142
3. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-710 (Pubitemid 30179401)
4. Jackson R, Lawes CMM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005;365:434-441 (Pubitemid 40179232)
5. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-798 (Pubitemid 43754299)
6. Grover SA, Lowensteyn I, Joseph L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Arch Intern Med 2007;167:2296-2303 (Pubitemid 350179523)
7. Jackson R, Wells S. Prediction is difficult, particularly about the future [comment]. Arch Intern Med 2007;167:2286-2287 (Pubitemid 350179520)
8. New Zealand Guideline Group. The assessment and management of cardiovascular risk. Wellington, New Zealand, 2003.
9. Anderson KM, Odell PM, Wilson PWF, et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-298
10. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913 (Pubitemid 35472129)
11. Prospective Studies Collaborations; Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-1839
12. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-753
13. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures [see comment]. BMJ 2002;324:827-830 (Pubitemid 34280736)
14. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003;327:741-744 (Pubitemid 37176763)
15. Goodyear-Smith F, Arroll B, Chan L, et al. Patients prefer pictures to numbers to express cardiovascular benefit from treatment. Ann Fam Med 2008;6:213-217 (Pubitemid 351716780)
16. Spiegelhalter DJ. Understanding uncertainty. Ann Fam Med 2008;6:196-197
17. Graham I, Atar D, Borch-Johnsen K, et al. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2007;14(Suppl 2):S1-88.
18. Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J 2007;153:722-731 (Pubitemid 46628793)
19. Hense H-W, Schulte H, Lowel H, et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937-945 (Pubitemid 36559987)
20. McEwan P, Williams JE, Griffiths JD, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004;21:318-323 (Pubitemid 38519665)
21. Ramachandran S, French JM, Vanderpump MP, et al. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000;320:676-677 (Pubitemid 30179390)
22. Milne R, Gamble G, Whitlock G, et al. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors. N Z Med J 2003;116:U663. (Pubitemid 41386907)
23. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136. (Pubitemid 47172233)